TLSA (Tiziana Life Sciences) Days Payable: 0.00 (As of Dec. 2025)

What is Tiziana Life Sciences Days Payable?

Tiziana Life Sciences TLSA +0.89% 30 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates TLSA with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 708 Biotechnology companies, Tiziana Life Sciences ranks worse than 141242.8% on this metric.

Tiziana Life Sciences's average Accounts Payable for the six months ended in Dec. 2025 was $6.33 Mil. Tiziana Life Sciences's Cost of Goods Sold for the six months ended in Dec. 2025 was $0.00 Mil.

The historical rank and industry rank for Tiziana Life Sciences's Days Payable or its related term are showing as below:

TLSA's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Tiziana Life Sciences's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).

Tiziana Life Sciences Days Payable Related Terms

Tiziana Life Sciences Days Payable Historical Data

* Premium members only.

The historical data trend for Tiziana Life Sciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tiziana Life Sciences Days Payable Chart

Tiziana Life Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

Tiziana Life Sciences Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

TLSA vs DTIL, MIST, EQ: Days Payable Comparison

For the Biotechnology subindustry, Tiziana Life Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tiziana Life Sciences Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tiziana Life Sciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Tiziana Life Sciences's Days Payable falls into.

Save Embed

30GF Score

Tiziana Life Sciences Ltd TLSA

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Tiziana Life Sciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Tiziana Life Sciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (5.58	+	7.173)	/	2 )	/	0	*	365
=	6.3765					/	0	*	365
=	N/A

Tiziana Life Sciences's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

	Days Payable (Q: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2025 )	+	Accounts Payable (Q: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
=	( (5.479	+	7.173)	/	2 )	/	0	*	365 / 2
=	6.326					/	0	*	365 / 2
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Tiziana Life Sciences (TLSA) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tiziana Life Sciences and its competitors. According to the industry distribution chart, Tiziana Life Sciences ranks #999999 out of 708 companies in the Biotechnology industry.

Is Tiziana Life Sciences' Days Payable too high?

Tiziana Life Sciences' current Days Payable is 0.00. Based on the distribution chart, Tiziana Life Sciences ranks #999999 out of 708 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Tiziana Life Sciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.

How does Tiziana Life Sciences' Days Payable compare to DTIL and MIST?

According to the Biotechnology industry distribution chart, Tiziana Life Sciences ranks #999999 out of 708 companies for Days Payable. This places Tiziana Life Sciences in the lower half of its industry. The industry median Days Payable is 113.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.56, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tiziana Life Sciences and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tiziana Life Sciences's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Tiziana Life Sciences stock overvalued right now?

Tiziana Life Sciences (TLSA) has a current Days Payable of 0.00. The current Days Payable is 0.00. Tiziana Life Sciences' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Tiziana Life Sciences (TLSA), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tiziana Life Sciences Business Description

Industry Healthcare Biotechnology

Comparable Companies DTIL MIST EQ MDWD OKUR QTTB ABOS PLX TNYA GALT VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 0RP:Germany

Address 2 Church Street, Clarendon House, Hamilton, BMU, HM 11

Website https://www.tizianalifesciences.com

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

30GF Score

Get the complete analysis for TLSA

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13

Price

View TLSA Analysis

See Days Payable data for all stocks →